Skip to content
Reipet – Lifestyle
Author:
Beyond Air™
Beyond Cancer Reports Early Clinical Activity and Favorable Safety Profile with Interim Data from Phase 1 UNO Trial
March 17, 2026
Beyond Air to Participate in the 38th Annual Roth Conference in March
March 11, 2026
Beyond Air® Announces Termination of Agreement to Sell Its NeuroNOS Subsidiary to XTL Biopharmaceuticals Ltd.
March 10, 2026
←
Previous Page
1
2